MediGlobo is a specialized team dedicated to driving positive changes in global healthcare. Leveraging advanced technologies, we make medical care accessible and convenient on a global scale. Our primary focus is on building a sustainable and inclusive ecosystem for both patients and healthcare professionals. We firmly believe in the universality of healthcare and tirelessly strive to make this vision a reality.
Our innovative approach and unwavering commitment to excellence set us apart from the competition, fueling significant advancements in the global medical sector. Through our efforts, we are fostering a transformative impact that benefits individuals worldwide, ensuring a healthier and brighter future for all.
EndoNeuro is a distributor of stents in the EspĆrito Santo and Rio de Janeiro regions, specializing in wholesale trade of medical, surgical, hospital, and laboratory instruments and materials. We offer a comprehensive range of products, including stethoscopes, scalpels, and other essential medical instruments. We collaborate with internationally recognized manufacturers, prioritizing quality and safety. In addition to stents, our product range includes diagnostic kits, pacemakers, gloves, syringes, and more. Our highly qualified team is committed to providing personalized assistance and technical guidance. We aim to establish strong partnerships with healthcare facilities, clinics, and professionals to enhance healthcare quality in the region. If you’re seeking a reliable partner in medical supplies, EndoNeuro is ready to meet your needs and contribute to healthcare excellence
Established in 2014, GF Medika is a leading distributor specializing in stents and endovascular products. Based in Porto Alegre, Brazil, we bring over 15 years of industry experience to the market, holding comprehensive regulatory approvals. Serving a diverse clientele, including prestigious hospitals and insurance providers, our seasoned team is dedicated to delivering top-quality endovascular solutions. We have forged valuable partnerships with global companies and offer a complete range of services, from registration and imports to marketing and support. At GF Medika, our focus remains unwavering ā delivering excellence in stent distribution to enhance medical practices across the region.
Each state has its own particularities but to set the big players of interest in each state, we evaluated the number of coronary rooms (clinic, chirurgical and coronary ICU) for each institution, once the stent use tends to be direct related to the number of coronary surgeries. To each state we selected the three main institutions as BIG MARKETING PLAYERS AND REFERENCE.
The 78th Brazilian Congress of Cardiology, which takes place between the 28th and 30th of September, at the FIERGS Events Center, will bring together more than eight thousand people, including speakers and congressmen. The event, one of the most important in the specialty, will make Brazil the global center of world cardiology with the presence of physicians and scientists from different countries. The most important clinical studies and scientific research will be presented at the Congress, as well as new guidelines that will guide the main treatments for cardiovascular diseases.
On behalf of the Cardiogeriatrics Department of the Brazilian Society of Cardiology, I have the honor of inviting you to participate in the XX Brazilian Congress of Cardiogeriatrics.Ā The city of SĆ£o Paulo was chosen to host the return of DECAGE’s in-person activities in 2023.Ā With the central theme: āPreventing and treating comorbidities in the elderlyā, the Scientific Committee, under the coordination of the Scientific Director of DECAGE, Dr. Izo Helber, is developing a program that covers the main pathologies of elderly people with heart disease, with an emphasis on practical and objective discussions.Ā We will have the opportunity to answer questions and exchange experiences with renowned national and international guests.We wish everyone a wonderful Congress.
From November 16th to 18th, 2023, SĆ£o Paulo will host the 19th Congress of the SBC Arterial Hypertension Department, which will have ”Ā Science, Innovation and New Directions in Clinical Practice”Ā as its central theme.
The congress will address advances and innovations in the treatment of hypertension, in addition to discussing new guidelines and promoting multidisciplinary interaction between specialists.
We will bring together more than 200 national and international speakers, who will promote scientific discussions on hypertension, obesity, metabolic diseases, diabetes and the impacts of high blood pressure on the kidneys and brain, among other extremely relevant topics.
40 years ago, the first Cardiac Arrhythmia Congress was held, promoted by the former Department of Arrhythmia and Clinical Electrophysiology (DAEC) of the Brazilian Society of Cardiology.Ā We are here again welcoming you to the 40th Brazilian Congress on Cardiac Arrhythmias!Ā A year of celebration and great pride for all of us.Ā The city chosen for this special moment is Rio de Janeiro.
The program is being prepared with great care and we will be honored to welcome several international speakers to exchange experiences.Ā Hands-on training stations and clinical case discussions will be highlighted.Ā Additionally, we include update sessions on key guidelines and reviews of technological innovations in recent years.
The main topics of cardiology will be covered both in the format of clinical case discussions and in lectures with our clinical staff.Ā We seek an interactive event with direct public participation, always addressing the most relevant issues for our specialty.
Our traditional highlight will be held where the main scientific articles are presented.
Ā
DEICĀ andĀ ESC’s Heart Failure Association are strengthening their relationship andĀ promotingĀ several events together.Ā This is in line with the current management’s plan to promote theĀ internationalization of DEICĀ , opening doors for exchanges, joint events and other actions such as exchange of fellows and participation in guidelines similar to the Japanese Society and others.
The Department of Heart Failure of the Brazilian Society of Cardiology (DEIC) announces the city that will host the next DEIC 2024 Congress. The event, which is the largest in Latin America, will take place in Recife, from August 8th to 10th next year.Ā āWe will maintain the same strategy as this edition, with a greater number of people invited to participate in the Scientific Committee to have a more plural vision and inclusion of themesā, says the president of the Department, Dr. MĆŗcio Tavares de Oliveira JĆŗnior.
We start developing a app to make fast and easy our Global health care communication.
Distributors have very high TARGET GOAL and MINIMUM PERIODIC PURCHASE AGREEMENTS that are not consistent with market performance.
Fair Goals
Through the close relationship with the distributor and the analysis of the market indicators MediGlobo intend to have its own store warehouse facility and plan with the distributors fair target goals, providing marketing materials and benefits to boost sales.
Brands doesn’t have a close relationship with the distributors
Communication
Our main strategy is to have a close relationship with the distributors through exclusive channels. The MediGlobo app is going to be used by the distributor as an open channel to the communication with MediGlobo and also provide features to be used on Marketing and approach with the consumer with complete info about the products.
MediGlobo is inviting a select group of cardiologists to become Translumina Ambassadors. Each State is going to have a nominated Ambassador, recognized by its influence and experience on the cardiology field. This ambassador will have two main objectives. The first one is to provide information and technical support to the distributors in the state and be the representative of the brand on the main cadiology events. The ambassadors will be responsable for assisting in the first uses of Translumina products and assure its correct uses, providing feedback on market opening and avoiding implantation problems.
The second goal is to provide information to MediGlobo about the market needs, new technologic features and new products on the market. This way MediGlobo can keep in touch with transluminal and update the commercial strategies based on the market changes.